USPUSP-NF
This is a preview of
USP-NF/PF content.
Subscriber?
Access here! Not a subscriber?
Learn more!
Risedronate Sodium Delayed-Release Tablets

DEFINITION

Risedronate Sodium Delayed-Release Tablets contain NLT 90.0% and NMT 110.0% of the labeled amount of risedronate sodium (C7H10NNaO7P2).

USP REFERENCE STANDARDS FOR PURCHASE

USP Risedronate Related Compound A RS
USP Risedronate Sodium RS
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!Not a subscriber?
Learn more!